Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Zhongguo Zhong Yao Za Zhi ; 41(21): 4060-4065, 2016 Nov.
Article in Zh | MEDLINE | ID: mdl-28929696

ABSTRACT

To analyze the clinical application of Cervus and Cucumis Polypeptide injection in the real world, in order to define the characteristics of clinical drug use and correlation, and provide reference for risk management and further study for Cervus and Cucumis Polypeptide injection. Descriptive analysis and association rules analysis were performed on 37 721 cases using Cervus and Cucumis Polypeptide injection in 26 hospitals nationwide. Cervus and Cucumis Polypeptide injection were mostly adopted by patients aged between 45 and 64(39.84%); mainly used to treat fracture patients in clinic(17 362 cases, 33.97%); 12 mL(41.81%) was the commonest dosage. And the course of treatment mainly lasted for 1-3 days(28 467 cases, 76.26%), which was basically consistent with the description of package insert. In clinic, traditional Chinese medicines, such as blood activating and stasis removing agents and Bushen Zhuanggu agents, were frequently combined with it(rule support degree of 19.38%). Such western medicine as antibiotics and nutritional drugs were frequently combined with it(rule support 39.9%). The main single combined medicine were vitamin C(13 202 cases, 35%), and Jintiange capsule(7 285 cases, 19.31%). The commonly used combined drug pairs were Hulisan capsule and Jintiange capsule (rule support 4.458%), phenobarbital and ceftazidime azole oxazoline(rule support degree of 10.62%). Cervus and Cucumis Polypeptide injection is mainly adopted by elderly patients in clinic, used to treat fracture patients, and often combined with blood activating and stasis removing agents, Bushen Zhuanggu agents, antibiotics, and nutritional medicine to enhance fracture healing. In clinical application, attention shall be paid to drug safety of elderly patients and types of combined medicines and their interaction, so as to prevent adverse reactions.


Subject(s)
Drug Utilization , Hospital Information Systems , Materia Medica/therapeutic use , Medicine, Chinese Traditional , Animals , China , Cucumis/chemistry , Deer , Drugs, Chinese Herbal/therapeutic use , Fractures, Bone/drug therapy , Humans , Injections , Peptides/therapeutic use
2.
Expert Opin Ther Targets ; 6(1): 57-72, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11901481

ABSTRACT

The thymus provides an optimal cellular and humoral microenvironment for a cell line committed differentiation of haematopoietic stem cells. The immigration process requires the secretion of at least one peptide, called thymotaxin, by cells of the reticulo-epithelial (RE) network of the thymic stromal cellular microenvironment. The thymic RE cells are functionally specialised based on their intrathymic location and this differentiation is modulated by various interaction signals of differentiating Thymocytes and other nonlymphatic, haematopoietic stem cells. The subcapsular, endocrine, RE cell layer is comprised of cells filled with periodic acid Shiff's-positive granules, which also express A2B5/TE4 cell surface antigens and MHC Class I (HLA A, B, C) molecules. Thymic nurse cells also produce thymosins beta 3 and beta 4 and display a neuroendocrine cell specific immunophenotype (IP): Thy-1+, A2B5+, TT+, TE4+, UJ13/A+, UJ127.11+, UJ167.11+, UJ181.4+ and presence of common leukocyte antigen (CLA+). Cortical RE cells express a surface antigen, gp200-MR6, which plays a significant role of thymocyte differentiation. Medullar RE cells display MHC Class II (HLA-DP, HLA-DQ, HLA-DR) molecule restriction. Thymic RE cells also produce numerous cytokines that are important in various stages of haematopoietic cell activation and differentiation. The co-existence of pituitary hormone and neuropeptide secretion, as well as the production of a number of interleukins and growth factors, and expression of receptors for all, by RE cells is an unique molecular biological phenomenon. Thymic neuroendocrine polypeptides are the source of self antigens presented by the MHC molecules to differentiating haematopoietic stem cells. On the level of individual RE cells, the numerous projections associated with a single cell, which engulf developing lymphocytes, nurturing and guiding them in their maturation, may differ in their hormone production and/or hormone receptor expression profile, thus allowing a single cell to be involved in distinct, separate steps of the T-cell and other haematopoietic cell maturation process. Thymic RE cells represent an important cellular and humoural network within the thymic microenvironment and are involved in the homeopathic regulation mechanisms of the multicellular organism. The intrathymic T-lymphocyte selection is a complex, multistep process, influenced by several functionally specialised RE cells and under immuno-neuroendocrine regulation control reflecting the dynamic changes of the mammalian organism.


Subject(s)
Bone and Bones/pathology , Osteoporosis/drug therapy , Animals , Bone and Bones/drug effects , Bone and Bones/metabolism , Bone and Bones/physiology , Humans , Lipid Metabolism , Osteoporosis/metabolism , Osteoporosis/pathology , Peptides/therapeutic use , Steroids/therapeutic use
3.
Yao Xue Xue Bao ; 27(5): 321-4, 1992.
Article in English | MEDLINE | ID: mdl-1442050

ABSTRACT

An anti-inflammatory compound was purified and isolated from pilose antler of Cervus nippon Temminck by dialysis, gel filtration and ion-exchange chromatography techniques. HPLC and N-terminal amion acid analysis identified the compound as a homogeneous peptide. The peptide is composed of 68 amino acids and its molecular weight as determined by amino analysis, is about 7200.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Antlers/chemistry , Deer , Materia Medica/chemistry , Peptides/isolation & purification , Amino Acids/analysis , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Edema/drug therapy , Peptides/chemistry , Peptides/therapeutic use , Rats
4.
Zhongguo Zhong Yao Za Zhi ; 25(2): 105-7, 2000 Feb.
Article in Zh | MEDLINE | ID: mdl-12212070

ABSTRACT

OBJECTIVE: To investigate the preventive effect of cardiomyopeptidin of small molecular weight polypeptide on rat hearts injured by ischemia-reperfusion. METHODS: In a rat model injured by ischemia-reperfusion in the heart, observation was made on the influence of cardiomyopeptidin on the activities of creatine kinase (CK) and lactate dehydrogenase(LDH), as well as on the content of MDA in plasma after the preventive drug was used. RESULTS: Cardiomyopeptidin could obviously prevent the injury caused by ischemia-reperfusion, reduce the activities of CK and LDH and the content of MDA in a dose-dependent manner. CONCLUSION: Cardiomyopeptidin has a preventive effect on myocardium injured by ischemia-reperfusion and this may be related to its reducing the release of myocardial enzyme and anti-lipoperoxidation.


Subject(s)
Materia Medica/therapeutic use , Myocardial Reperfusion Injury/prevention & control , Peptides/therapeutic use , Animals , Creatine Kinase/blood , Female , L-Lactate Dehydrogenase/blood , Male , Malondialdehyde/blood , Molecular Weight , Myocardial Reperfusion Injury/blood , Myocardium/chemistry , Peptides/chemistry , Rats , Rats, Wistar , Swine
5.
Zhongguo Yao Li Xue Bao ; 15(3): 282-4, 1994 May.
Article in Zh | MEDLINE | ID: mdl-7976389

ABSTRACT

Pilose antler peptide (PAP:MW:7200; amino acid residue:68) isolated from the antlers of Cervus nippon temminck 10 and 20 mg.kg-1 i.p. produced inhibitions towards acute and chronic inflammations in a dose-dependent manner. PAP reduced ascorbic acid and cholesterol contents in adrenal glands and decreased the serum hydrocortisone level of rats. The reduction of ascorbic acid and cholesterol contents were unaffected by the pretreatment of dexamethasone. PAP also showed an anti-inflammatory action on the swelling of carrageenan-induced hind paw in adrenalectomized rats. The results suggest that the anti-inflammatory effects of PAP do not depend absolutely on pituitary-adrenal system.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antlers , Deer , Materia Medica , Peptides/pharmacology , Adrenal Glands/metabolism , Animals , Antlers/chemistry , Ascorbic Acid/metabolism , Cholesterol/metabolism , Edema/drug therapy , Female , Hydrocortisone/blood , Male , Materia Medica/chemistry , Mice , Peptides/therapeutic use , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL